{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:36:27Z","timestamp":1790289387894,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008360.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000}}],"reference-count":60,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008360.pub5","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T18:58:15Z","timestamp":1572029895000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease"],"prefix":"10.1002","volume":"2019","author":[{"given":"Lise J","family":"Estcourt","sequence":"first","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"University of Oxford; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS); Botnar Research Centre, Windmill Road Oxford Oxfordshire UK OX3 7LD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialena","family":"Trivella","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Botnar Research Centre Windmill Road Oxford UK OX3 7LD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R","family":"Hambleton","sequence":"additional","affiliation":[{"name":"Caribbean Institute for Health Research; Chronic Disease Research Centre; The University of the West Indies Jemotts Lane Bridgetown Barbados BB11115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Cho","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Colindale Avenue London UK NW9 5BG"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"10.1002\/14651858.CD008360.pub5-BIB0001|cit1","unstructured":"Atilla E Topcuoglu P Yavasoglu S Karakaya A Gencturk C Bozdag S Arslan O A randomized comparison of hemoglobin content-based vs standard (unit-based) RBC transfusion policy efficiencies Vox Sanguinis 2011 121. Abstract No. P-303"},{"issue":"3","key":"10.1002\/14651858.CD008360.pub5-BIB0002|cit2","first-page":"244","article-title":"A randomized comparison of hemoglobin content-based versus standard (unit-based) red blood cell transfusion policy","volume":"34","author":"Atilla","journal-title":"Turk J Haematol"},{"issue":"3","key":"10.1002\/14651858.CD008360.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and hemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: rResults of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/IJGM.S66610","article-title":"Benefits of chronic blood transfusion in hemoglobin E\/\u03b2 thalassemia with pulmonary arterial hypertension","volume":"7","author":"Chueamuangphan","year":"2014","journal-title":"International Journal of General Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008360.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2014-12-614370","article-title":"Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease","volume":"126","author":"Detterich","year":"2015","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.resp.2015.11.006","article-title":"Lung function, transfusion, pulmonary capillary blood volume and sickle cell disease","volume":"222","author":"Lunt","year":"2016","journal-title":"Respiratory Physiology & Neurobiology"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0007|cit7","unstructured":"NCT00023296 Nitric oxide and transfusion therapy for sickle cell patients with pulmonary hypertension ClinicalTrials.gov NCT00023296"},{"issue":"2","key":"10.1002\/14651858.CD008360.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.2006.06409.x","article-title":"Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2","volume":"136","author":"Styles","year":"2006","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD008360.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2141.2012.09105.x","article-title":"Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)","volume":"157","author":"Styles","year":"2012","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD008360.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0197-2456(97)00099-8","article-title":"Stroke prevention trial in sickle cell anemia","volume":"19","author":"Adams","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD008360.pub5-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007843.pub2","article-title":"Blood transfusions for treating acute chest syndrome in people with sickle cell disease","author":"Alhashimi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008360.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/archdischild-2013-303773","article-title":"Sickle cell disease: a neglected chronic disease of increasing global health importance","volume":"100","author":"Chakravorty","year":"2015","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/asheducation-2013.1.439","article-title":"Transfusion therapy for sickle cell disease: a balancing act","volume":"2013","author":"Chou","year":"2013","journal-title":"Hematology"},{"issue":"6","key":"10.1002\/14651858.CD008360.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD008360.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(82)90763-X","article-title":"Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies","volume":"73","author":"Collins","year":"1982","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008360.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.1986.tb05546.x","article-title":"Red cell alloimmunization in sickle cell disease","volume":"63","author":"Davies","year":"1986","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0017|cit17","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9 Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane handbook for systematic reviews of interventions Version. 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0018|cit18","unstructured":"US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute Expert Panel Report 2014 Evidence-based management of sickle cell disease: Expert Panel Report, 2014 http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/sickle-cell-disease-guidelines"},{"issue":"7","key":"10.1002\/14651858.CD008360.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/515S1a","article-title":"Sickle-cell disease","volume":"515","author":"Gravitz","year":"2014","journal-title":"Nature"},{"issue":"6S4","key":"10.1002\/14651858.CD008360.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa. A neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"American Journal of Preventive Medicine"},{"issue":"11","key":"10.1002\/14651858.CD008360.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1172\/JCI119442","article-title":"Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium","volume":"99","author":"Hebbel","year":"1997","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0023|cit23","unstructured":"Higgins JP Green S editor(s) Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0024|cit24","unstructured":"Higgins JP Deeks JJ editor(s) Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0025|cit25","unstructured":"Higgins JP Altman DG Sterne JA on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaborartion, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0026|cit26","unstructured":"Higgins JP Deeks JJ Altman DG on behalf of the Cochrane Statistical Methods Group editor(s) Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines","volume":"21","author":"Josephson Cassandra","year":"2007","journal-title":"Transfusion Medicine Reviews"},{"issue":"5-6","key":"10.1002\/14651858.CD008360.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/03630269.2011.621149","article-title":"Pulmonary complications of sickle cell disease","volume":"35","author":"Khoury","year":"2011","journal-title":"Hemoglobin"},{"issue":"11","key":"10.1002\/14651858.CD008360.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1164\/rccm.200601-125OC","article-title":"Abnormal pulmonary function in adults with sickle cell anemia","volume":"173","author":"Klings","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0030|cit30","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD008360.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.2005.05625.x","article-title":"Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension","volume":"130","author":"Machado","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Machado RF Barst RJ Yovetich NA Hassell KL Goldsmith JC Woolson R Safety and efficacy of sildenafil therapy for doppler-defined pulmonary hypertension in patients with sickle cell disease: preliminary results of the walk-PHaSST clinical trial 51st American Society of Hematology Annual Meeting and Exposition 2009","DOI":"10.1182\/blood.V114.22.571.571"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Mehari A Klings ES Chronic pulmonary complications of sickle cell disease Chest 2016 1313 24","DOI":"10.1016\/j.chest.2015.11.016"},{"issue":"4","key":"10.1002\/14651858.CD008360.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-Analyses:the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008360.pub5-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003426.pub3","article-title":"Drugs for preventing red blood cell dehydration in people with sickle cell disease","author":"Nagalla","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0036|cit36","unstructured":"NICE (National Institute for Health and Care Excellence) Sickle cell disease http:\/\/cks.nice.org.uk\/sickle-cell-disease"},{"issue":"24","key":"10.1002\/14651858.CD008360.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0040|cit40","first-page":"447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"1","author":"Porter","year":"2013","journal-title":"ASH Education Program Book"},{"issue":"1","key":"10.1002\/14651858.CD008360.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00005792-198801000-00005","article-title":"Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure","volume":"67","author":"Powars","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0043|cit43","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"7","key":"10.1002\/14651858.CD008360.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3181c70e14","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease","volume":"339","author":"Scheunemann","year":"2010","journal-title":"The American Journal of the Medical Sciences"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1537-2995.1987.27387235626.x","article-title":"Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion","volume":"27","author":"Schmalzer","year":"1987","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0047|cit47","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group Chapter 11: Presenting results and \u2018Summary of findings\u2019 tables. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration 2011. Available from www.cochranehandbook.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0048|cit48","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P et al on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0049|cit49","unstructured":"Sterne JA Egger M Moher D on behalf of the Cochrane Bias Methods Group editor(s) Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"Systematic Reviews"},{"issue":"16","key":"10.1002\/14651858.CD008360.pub5-BIB0051|cit51","first-page":"[DOI: 10.1186\/1","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2141-9248.105655","article-title":"Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria","volume":"2","author":"Ubesie","year":"2012","journal-title":"Annals of Medical and Health Sciences Research"},{"issue":"23","key":"10.1002\/14651858.CD008360.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008360.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008360.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1378\/chest.10-0317","article-title":"Pulmonary complications of hemoglobinopathies","volume":"138","author":"Vij","year":"2010","journal-title":"Chest"},{"issue":"10","key":"10.1002\/14651858.CD008360.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD008360.pub5-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008360","article-title":"Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease","author":"Cho","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD008360.pub5-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008360.pub2","article-title":"Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease","author":"Cho","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008360.pub5-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008360.pub3","article-title":"Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease","author":"Cho","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD008360.pub5-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008360.pub4","article-title":"Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease","author":"Estcourt","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008360.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:19:35Z","timestamp":1628547575000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008360.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008360.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]}}}